Aurinia Pharmaceuticals Inc. Cost of Revenue in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to Q3 2025.
  • Aurinia Pharmaceuticals Inc. Cost of Revenue for the quarter ending September 30, 2025 was $8.18M, a 35.5% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. Cost of Revenue for the twelve months ending September 30, 2025 was $29.4M, a 4.72% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2024 was $28.2M, a 99.7% increase from 2023.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2023 was $14.1M, a 150% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2022 was $5.66M, a 419% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

Aurinia Pharmaceuticals Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $29.4M $8.18M +$2.14M +35.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $27.3M $7.12M -$1.79M -20.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $29.1M $8.57M +$822K +10.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $28.2M $5.55M +$157K +2.91% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $28.1M $6.04M -$734K -10.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $28.8M $8.91M +$7.35M +470% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-31
Q1 2024 $21.5M $7.75M +$7.33M +1741% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $14.1M $5.4M +$4.03M +296% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $10.1M $6.77M +$4.32M +177% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $5.79M $1.56M -$36K -2.25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $5.83M $421K +$165K +64.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $5.66M $1.36M +$881K +183% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $4.78M $2.45M +$2.19M +863% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.59M $1.6M +$1.29M +419% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.3M $256K +$208K +433% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.09M $481K +$481K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $610K $254K +$254K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $356K $308K +$308K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $48K $48K +$48K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06

Aurinia Pharmaceuticals Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $28.2M +$14.1M +99.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $14.1M +$8.48M +150% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $5.66M +$4.57M +419% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $1.09M +$1.09M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.